Loading...
Precision System Science Co., Ltd.
PCNEF•PNK
Healthcare
Medical - Diagnostics & Research
$2.28
$0.00(0.00%)

Financial performance has remained strong, with revenue growing from $1.08B in Q3 2023 to $1.12B in Q2 2024. Gross profit continued to perform well, with margins at 26% in the latest quarter. Operating income reached -$64.00M in Q2 2024, holding a steady -6% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$4.00M. Net income rose to -$77.00M, keeping EPS at -$2.79. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan